On November 10, 2023, Joseph McGuire and Dr. Mihail Obrocea were terminated from their positions as Chief Financial Officer (and principal financial and accounting officer) and Chief Medical Officer, respectively, of the Company, effective immediately, as part of the Company’s effort to streamline operations.
Hudson Global, Inc. (the “Company”) announced on November 15, 2023 (the “Effective Date”) the appointment of Jacob “Jake” Zabkowicz as Global Chief Executive Officer at Hudson RPO Holdings LLC, a wholly-owned subsidiary of the Company (“Hudson RPO”).
Departed
Amir Ayalon
Chief Financial Officer
Tingo Group, Inc.
Effective
2023-11-11
Successor
Kenneth Denos and Dozy Mmobuosi
Filed
November 15, 2023, 6:59 PM ET
On November 11, 2023, Amir Ayalon notified the Company of his decision to resign as the Company’s Chief Financial Officer, effective immediately, for personal reasons.
Appointed
(interim)
Dozy Mmobuosi
interim co-Principal Financial and Accounting Officer
Tingo Group, Inc.
Effective
2023-11-13
Filed
November 15, 2023, 6:59 PM ET
Kenneth Denos and Dozy Mmobuosi, the Company’s interim co-Chief Executive Officers were appointed as the Company’s interim co-Principal Financial and Accounting Officers, effective November 13, 2023.
Appointed
(interim)
Kenneth Denos
interim co-Principal Financial and Accounting Officer
Tingo Group, Inc.
Effective
2023-11-13
Filed
November 15, 2023, 6:59 PM ET
Kenneth Denos and Dozy Mmobuosi, the Company’s interim co-Chief Executive Officers were appointed as the Company’s interim co-Principal Financial and Accounting Officers, effective November 13, 2023.
Appointed
(interim)
John Faieta
interim Chief Financial Officer
Near Intelligence, Inc.
Effective
2023-11-10
Filed
November 15, 2023, 6:59 PM ET
On November 10, 2023, the Company entered into an employment agreement with John Faieta for continued service as interim Chief Financial Officer.
Departed
Anil Mathews
Chief Executive Officer
Near Intelligence, Inc.
Effective
2023-11-14
Successor
Gladys Kong
Filed
November 15, 2023, 6:59 PM ET
On November 14, 2023, the Restructuring Committee of the Board of Directors (the “ Restructuring Committee ”) of Near Intelligence, Inc. (the “ Company ”) terminated the employment of Anil Mathews, the Company’s Chief Executive Officer, and Shobhit Shukla, the Company’s President, for cause, effective immediately, pursuant to the terms of their respective employment agreements.
Appointed
Gladys Kong
Chief Executive Officer
Near Intelligence, Inc.
Effective
2023-11-14
Filed
November 15, 2023, 6:59 PM ET
On November 10, 2023, the Company entered into retention bonus agreements with Gladys Kong, the Company’s new Chief Executive Officer, following the termination of Mr. Matthews.
the Company concurrently announced that Richard S. Dziadzio ceased serving as Executive Vice President, Chief Financial Officer, effective immediately, and will depart from the Company on March 18, 2024
On November 14, 2023, the board of directors of the Company and the Bank appointed Walter J. Phifer as Chief Financial Officer of the Company and the Bank, effective January 1, 2024.
Role change
Ana J. Schrank
Chief Financial Officer and Chief Accounting Officer
Invitae Corp
Effective
2023-11-21
Filed
November 15, 2023, 6:59 PM ET
appoint Ana J. Schrank, the Company’s Chief Financial Officer, as its Chief Accounting Officer (Principal Accounting Officer), in addition to her current position as Chief Financial Officer, effective November 21, 2023.
On November 8, 2023, Michael Linacre, Chief Financial Officer of Innovative Solutions and Support, Inc. (the “Company”), notified the Company that he is resigning from all of his positions with the Company, effective immediately.
The Company also announced that Rolando J. Guillot, Senior Vice President – Operations and Chief Operating Officer, has been named to serve as Interim President and Chief Executive Officer effective January 1, 2024 in addition to his current role.
Frank J. Krejci, President and Chief Executive Officer, will retire from employment with the Company and resign from the Company’s Board of Directors (“Board”) effective December 31, 2023.
Departed
(interim)
Stephen J. Moore
Interim Chief Financial Officer
MachTen, Inc.
Effective
2023-11-14
Filed
November 14, 2023, 6:59 PM ET
accepted the resignation of Stephen J. Moore as the Company’s Interim Chief Financial Officer.
Role change
Ronald L. Zimmerly, Jr.
Chief Executive Officer
MIDDLEFIELD BANC CORP
Effective
2024-01-01
Filed
November 14, 2023, 6:59 PM ET
On November 14, 2023, Middlefield Banc Corp. (the “Company”) announced that the Board of Directors of the Company will appoint Ronald L. Zimmerly, Jr. to serve as Chief Executive Officer of the Company and of The Middlefield Banking Company (the “Bank”), the wholly owned bank subsidiary of the Company, effective January 1, 2024.
Departed
James R. Heslop, II
Chief Executive Officer
MIDDLEFIELD BANC CORP
Effective
2024-01-01
Successor
Ronald L. Zimmerly, Jr.
Filed
November 14, 2023, 6:59 PM ET
On November 13, 2023, James R. Heslop, II, Chief Executive Officer and director of the Company and the Bank, notified the Company’s Board that he will resign as Chief Executive Officer of the Company and the Bank effective January 1, 2024.
Role change
(interim)
Leonard S. Paolillo
interim President and Chief Executive Officer
IMPEL PHARMACEUTICALS INC
Effective
2023-11-04
Filed
November 14, 2023, 6:59 PM ET
the Board of Directors (the “ Board ”) of the Company appointed Leonard S. Paolillo, the Company’s Chief Commercial Officer, as interim President and Chief Executive Officer of the Company.
Departed
Adrian Adams
President and Chief Executive Officer
IMPEL PHARMACEUTICALS INC
Effective
2023-11-04
Successor
Leonard S. Paolillo
Filed
November 14, 2023, 6:59 PM ET
Adrian Adams resigned as chairman of the Board and as President and Chief Executive Officer of Impel Pharmaceuticals Inc.
Departed
Emeka Chukwu
Executive Vice President and Chief Financial Officer
Emeka Chukwu, the Company’s former Executive Vice President and Chief Financial Officer, ceased serving as the Company’s Executive Vice President and Chief Financial Officer on the Transition Date.
Appointed
Mark Lin
Executive Vice President and Chief Financial Officer
Semtech appointed Mark Lin to serve as the Company’s Executive Vice President and Chief Financial Officer effective October 2, 2023
Departed
George Bchara
Executive Vice President and Chief Financial Officer
CONNS INC
Effective
2023-11-17
Successor
Timothy Santo
Filed
November 14, 2023, 6:59 PM ET
On November 13, 2023, Mr. George Bchara, Executive Vice President and Chief Financial Officer of Conn’s, Inc. (the “Company”), submitted his voluntary resignation as Chief Financial Officer of the Company, effective November 17, 2023.
Appointed
(interim)
Timothy Santo
Interim Chief Financial Officer
CONNS INC
Effective
2023-11-17
Filed
November 14, 2023, 6:59 PM ET
Effective November 17, 2023, the Company promoted Mr. Timothy Santo, age 47, to Interim Chief Financial Officer.
Michael A. Kuglin, who has served as the Partnership’s Chief Financial Officer since 2014 and as its Chief Accounting Officer since 2009, will continue in his role as the Partnership’s Chief Financial Officer.
Departed
Erik Carlson
President and Chief Executive Officer
DISH Network CORP
Effective
2023-11-12
Successor
Hamid Akhavan
Filed
November 13, 2023, 6:59 PM ET
Mr. Carlson notified DISH of his intention to resign as President and Chief Executive Officer of DISH effective as of November 12, 2023
Appointed
Hamid Akhavan
President and Chief Executive Officer
DISH Network CORP
Effective
2023-11-13
Filed
November 13, 2023, 6:59 PM ET
On November 9, 2023, DISH Network Corporation (“DISH”) appointed Mr. Hamid Akhavan, the current Chief Executive Officer and President of EchoStar Corporation (“EchoStar”), to the additional role of President and Chief Executive Officer of DISH effective as of November 13, 2023.
On November 7, 2023, the Board of Directors of RE/MAX Holdings, Inc. (the “Company”) appointed Erik Carlson as the Company’s Chief Executive Officer, effective November 13, 2023
the Board appointed Marco Fregenal, President and Chief Financial Officer of the Company, to serve as Chief Executive Officer, in addition to his current responsibilities
Joshua Harley, the Chief Executive Officer, Director and Chairman of the Board of Directors (the “Board”) of Fathom Holdings, Inc. (the “Company”) resigned from his role as CEO and Director of the Company, effective November 13, 2023.
On November 9, 2023, Jennifer Fox, the Chief Financial Officer of Nuvation Bio Inc. (the “Company”), notified the Company of her decision to pursue a new opportunity and resign from her position at the Company effective November 27, 2023.
Departed
Jason Judd
Senior Vice President, Chief Financial Officer and Treasurer
EXPRESS, INC.
Effective
2023-11-17
Successor
Mark Still
Filed
November 13, 2023, 6:59 PM ET
On November 6, 2023, Express, Inc. (the “Company”) received notice that Jason Judd, the Company’s Senior Vice President, Chief Financial Officer and Treasurer, is resigning, effective November 17, 2023, to pursue another opportunity.
Appointed
(interim)
Mark Still
Interim Chief Financial Officer and Treasurer
EXPRESS, INC.
Effective
2023-11-17
Filed
November 13, 2023, 6:59 PM ET
Effective upon Mr. Judd’s resignation, Mark Still will serve as the Company’s Interim Chief Financial Officer and Treasurer, in addition to his current role as Senior Vice President, Brand Finance and Planning & Allocation, reporting to Stewart Glendinning, the Company’s Chief Executive Officer.
Robert M. Patterson, Chairman of the Board of Directors and the President and Chief Executive Officer of Avient Corporation (the “Company”), notified the Board of Directors (the “Board”) of the Company that he will retire as President and Chief Executive Officer and as a member of the Board, effective as of December 1, 2023.
On November 13, 2023, the Company announced that, in connection with Mr. Patterson’s retirement, Dr. Ashish Khandpur has been appointed as President and Chief Executive Officer and a member of the Board, effective December 1, 2023.
the Board approved the appointment of Bruce Culleton, MD, as Chief Executive Officer and as a Class III director of the Company, effective as of the Effective Date.
the board of directors (the “Board”) of ProKidney Corp. (the “Company”) approved the termination, without cause, of Tim Bertram, Ph.D., Chief Executive Officer of the Company, effective November 15, 2023
Departed
Joseph J. Sarret
President and Chief Executive Officer
CohBar, Inc.
Effective
2023-11-10
Filed
November 13, 2023, 6:59 PM ET
Joseph J. Sarret, M.D., J.D., CohBar’s President and Chief Executive Officer, at the direction of the Board, ceased to be an officer of CohBar, effective as of November 10, 2023.
Departed
Jeffery F. Biunno
Chief Financial Officer
CohBar, Inc.
Effective
2023-11-10
Filed
November 13, 2023, 6:59 PM ET
Jeffery F. Biunno, CohBar’s Chief Financial Officer, at the direction of the Board, ceased to be an officer of CohBar, effective as of November 10, 2023.
Ian McAdams, previously the interim Co-Chief Financial Officer of the Company, has been named Chief Financial Officer of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.